In this edition:
– Remote pulmonary artery pressure monitoring in chronic HF
– CTS associated with subsequent HF
– RAS inhibition and outcomes in HFREF and advanced kidney disease
– CRP and incident HF risk in patients with CV disease
– LBBAP vs. BVP in CRT candidates
– Torsemide vs. furosemide in hospitalised HF: symptoms and QOL
– Anaemia: effect of sacubitril-valsartan
– Neurohormonal antagonist initiation after HF hospitalisation in older adults
– Predictors of long-term CV and non-CV mortality in HFPEF
– HF pharmacotherapies and outcomes in obese vs. nonobese HFREF patients
Download the Heart Failure Research Review: Issue 79, with commentary by Prof Andrew Coats (pdf)

